Ingevity CORP Form 4 insider transactions

Stuart Edward Woodcock Jr., EVP and President of Performance Materials at Ingevity Corp, reports changes in beneficial ownership due to vesting of restricted stock units and associated tax withholding.

Ryan C. Fisher, SVP, Gen. Counsel & Secretary of Ingevity Corp, reports acquisition and disposal of common stock due to RSU vesting and tax withholding.

Terrance M. Dyer, SVP and Chief HR Officer of Ingevity Corp, reports the acquisition of 4,627 restricted stock units.

Richard Allen White JR, SVP and President of Performance Chemicals at Ingevity Corp, reports the vesting of restricted stock units and associated tax withholding, along with a new grant of RSUs.

Phillip John Platt, SVP, Finance & CAO of Ingevity Corp, reports the vesting of restricted stock units and subsequent withholding of shares for tax obligations, along with a new grant of RSUs.

Steven Paul Hulme, SVP and President of APT at Ingevity Corp, sold shares to cover tax obligations related to vested restricted stock units.

Mary Dean Hall, EVP and CFO of Ingevity Corp, reports acquisition of 1,675 shares of common stock and disposition of 852 shares to cover tax obligations on vested performance-based restricted stock units (PSUs).

Steven Paul Hulme, SVP and President of APT at Ingevity Corp, reports acquisition and disposal of common stock related to performance-based restricted stock units (PSUs) vesting.

Richard Allen White JR, SVP and President of Performance Chemicals at Ingevity Corp, reports acquisition and disposal of common stock related to performance-based restricted stock units (PSUs).

Phillip John Platt, SVP of Finance & CAO at Ingevity Corp, reports the vesting of performance-based restricted stock units (PSUs) and shares withheld for tax obligations.

Ryan C. Fisher, SVP, Gen. Counsel & Secretary of Ingevity Corp, reports acquisition and disposal of common stock related to performance-based restricted stock units (PSUs).

Stuart Edward Woodcock Jr., EVP and President of Performance Materials at Ingevity Corp, reports acquisition of shares through performance-based restricted stock units (PSUs) and subsequent disposal to cover tax obligations.

Director J. Kevin Willis acquired 570 shares of Ingevity Corp common stock through vested deferred stock units.

Director J. Kevin Willis of Ingevity Corp reports the acquisition of 1,816 common stock shares through deferred stock units.

Luis M. Fernandez-Moreno, Interim President & CEO and Director of Ingevity Corp, reports acquisition of 26,696 shares and disposal of an unspecified amount of common stock on October 2, 2024, along with a grant of RSUs vesting on October 2, 2025.

Phillip John Platt, SVP of Finance at Ingevity Corp, reports the acquisition of 11,233 shares of common stock through a grant of RSUs.

Ryan C. Fisher, SVP, Gen. Counsel & Secretary of Ingevity Corp, reports the acquisition of 1,163 shares of common stock through a grant of Restricted Stock Units (RSUs) on July 5, 2024.

Richard Allen White JR, SVP and President of Performance Chemicals at Ingevity Corp, reports the withholding of shares to cover tax obligations related to vested restricted stock units.

Ryan C. Fisher, VP, CHRO, Deputy General Counsel & CCO of Ingevity Corp, reports a transaction involving common stock due to tax withholding obligations related to vested RSUs.

Director Jean S. Blackwell reported the grant of restricted stock units and holdings through a revocable trust in a recent SEC filing.

Director Luis Fernandez-Moreno received 2,800 shares of Ingevity Corp common stock in the form of restricted stock units that will vest on April 24, 2025.

Director Diane H. Gulyas reported the acquisition of 2,800 restricted stock units in Ingevity Corp, vesting on April 24, 2025, along with adjustments to her existing holdings.

Director Bruce D. Hoechner reported acquiring 2,800 shares of Ingevity Corp common stock through a grant of deferred stock units and disposing of 4,771 shares.

Director Frederick J. Lynch reported acquiring 2,800 shares of Ingevity Corp common stock on April 24, 2024, through a grant of restricted stock units.

Director Karen G. Narwold acquired 2,800 deferred stock units (DSUs) of Ingevity Corp on April 24, 2024, as part of her director compensation.

Director Daniel F. Sansone reports acquisition of 2,800 restricted stock units in Ingevity Corp, vesting on April 24, 2025.

Director Benjamin G. Wright acquired 2,800 deferred stock units (DSUs) of Ingevity Corp on April 24, 2024, electing to receive them in lieu of a restricted stock unit grant.

Mary Dean Hall, EVP & CFO of Ingevity Corp, reports the disposal of shares to cover tax obligations related to vested RSUs.

Phillip John Platt, CAO & VP, Bus Transform Lead of Ingevity Corp, reports acquisition and disposal of common stock related to RSU vesting and tax obligations.

Steven Paul Hulme, SVP and President of APT at Ingevity Corp, reports acquisition and disposal of common stock and restricted stock units (RSUs) on February 28, 2024, primarily related to tax withholding and RSU grants.